FreetownSyncom Formulations shipped nearly $15 million of tapentadol to West Africa after India’s 2025 ban, customs records show.
Consignments were labeled “Harmless Medicines for Human Consumption”; Sierra Leone declared kush a national emergency.
India’s drug regulator has not revoked any exporter licences.
Sources: Dawn
WHAT TAPENTADOL IS
Tapentadol is a synthetic opioid analgesic developed by Grünenthal in the 2000s, structurally distinct from tramadol but pharmacologically similar. It binds the mu-opioid receptor and inhibits norepinephrine reuptake — strong enough that the US DEA places it on Schedule II alongside oxycodone and fentanyl.
THE EXPORT LOOPHOLE
India's Central Drugs Standard Control Organisation regulates domestic sales but delegates export oversight to the Directorate General of Foreign Trade. A drug banned for domestic sale can still leave Indian ports legally if the destination country has not scheduled it — and most West African states have not.
WHY WEST AFRICA
Tramadol and tapentadol are not under international scheduling by the UN's 1961 and 1971 conventions. That gap means exporters face no INCB quota system, unlike morphine or fentanyl. West African regulators inherited colonial-era pharmacy laws that never anticipated synthetic opioids, leaving customs officers with no schedule to enforce against.
THE TRAMADOL PRECEDENT
This is the second wave. From roughly 2015 to 2018, Indian-manufactured tramadol at 225mg doses (well above any therapeutic prescription) flooded West Africa and the Sahel — Boko Haram fighters reportedly used it before operations. The WHO finally recommended international scheduling in 2022; manufacturers shifted to tapentadol, which had no such recommendation.
THE LABELING TRICK
"Harmless Medicines for Human Consumption" is not a regulatory category — it is a freight-forwarder description on a customs declaration. Indian export rules require accurate pharmaceutical labeling for INN (international nonproprietary names), but enforcement depends on physical inspection at the port of exit, which covers a tiny fraction of shipments.
WHO PAYS
Sierra Leone's health system, already among the world's most under-resourced, now allocates emergency funds to kush rehabilitation it cannot afford. India captures the export revenue; the receiving state absorbs the addiction, the overdoses, and the political cost of an epidemic it did not manufacture.